Company Filing History:
Years Active: 2021-2024
Title: Shalini Cornelio: Innovator in Kidney Injury Treatment
Introduction
Shalini Cornelio is a notable inventor based in Holmdel, NJ (US). She has made significant contributions to the field of medicine, particularly in the prevention and treatment of contrast-induced acute kidney injury. With a total of 2 patents, her work is paving the way for innovative therapeutic methods.
Latest Patents
Cornelio's latest patents focus on methods for preventing, reducing, and treating contrast-induced acute kidney injury. These methods include administering an inhibitor of fatty acid oxidation to patients in need. Additionally, her patents involve the use of trimetazidine or its pharmaceutically acceptable salts for the same purpose. Other methods outlined in her patents include the administration of various compounds such as etomoxir, oxfenicine, perhexiline, mildronate, or ranolazine, which are also aimed at preventing and treating this condition.
Career Highlights
Shalini Cornelio is currently associated with Saghmos Therapeutics, Inc., where she continues to develop her innovative ideas. Her work is characterized by a strong focus on improving patient outcomes through advanced medical treatments.
Collaborations
Cornelio collaborates with Anna Kazanchyan, who is also a key figure in her research endeavors. Together, they work towards enhancing the effectiveness of treatments for kidney injuries.
Conclusion
Shalini Cornelio's contributions to medical science, particularly in the area of kidney injury treatment, highlight her role as an influential inventor. Her innovative patents and ongoing work at Saghmos Therapeutics, Inc. demonstrate her commitment to advancing healthcare solutions.